openPR Logo
Press release

Telmisartan Market Growth Trend and Demand Outlook to 2027 - Macleods Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Jubilant Cadista, Aurobindo Pharma, Solco Healthcare

06-19-2019 05:47 AM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

"Global Telmisartan Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Telmisartan market with detailed market segmentation by indication, composition, distribution channel and geography.

Telmisartan Market to 2027 - Global Analysis and Forecasts Indication (Hypertension, Cardiac Arrest, Stroke); Composition (Single, Combinational); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00005565?sk

The report also includes the profiles of key Telmisartan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Mylan N.V.
- Hikma Pharmaceuticals PLC
- Exelan Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Ltd.
- Zydus Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- Jubilant Cadista.
- Aurobindo Pharma.
- Solco Healthcare
- Sandoz International GmbH

The reports cover key developments in the Telmisartan market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Telmisartan market are anticipated to lucrative growth opportunities in the future with the rising demand for Telmisartan in the global market. Below mentioned is the list of few companies engaged in the Telmisartan market.

Browse Complete Report at https://www.theinsightpartners.com/reports/telmisartan-market?sk

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Telmisartan Market - By Indication
1.3.2 Telmisartan Market - By Composition
1.3.3 Telmisartan Market - By Distribution Channel
1.3.4 Telmisartan Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. TELMISARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS

5. TELMISARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Inquire more at https://www.theinsightpartners.com/inquiry/TIPRE00005565?sk

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Telmisartan Market Growth Trend and Demand Outlook to 2027 - Macleods Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Jubilant Cadista, Aurobindo Pharma, Solco Healthcare here

News-ID: 1780132 • Views:

More Releases from The Insight Partners

Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope Till 2028
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Get PDF Sample
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market

All 5 Releases


More Releases for Telmisartan

Hypertension: The Driving Force Behind Telmisartan Market Growth
Hypertension, or high blood pressure, remains a global health crisis, affecting millions worldwide. This prevalence creates a significant and sustained demand for effective antihypertensive medications, positioning the Telmisartan market as a high-opportunity segment within the broader pharmaceutical landscape. Market Dynamics and Growth Drivers Telmisartan, an angiotensin II receptor blocker (ARB), is a widely prescribed medication for the treatment of hypertension. Its efficacy in lowering blood pressure, coupled with a generally well-tolerated safety
Telmisartan Dispersible Tablets Market: A Comprehensive Overview
As of 2023, the global telmisartan dispersible tablets market is valued at approximately USD 1.2 billion and is projected to reach around USD 2.1 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2032. Telmisartan Dispersible Tablets Market Overview The telmisartan dispersible tablets market is experiencing steady growth, primarily driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Telmisartan, an angiotensin receptor
Telmisartan Market Size, Share, Trends Report and Forecast 2024-2032
The telmisartan market value was USD 4 billion in 2023, driven by the global prevalence of hypertension, and aging populations. The market size is anticipated to grow at a CAGR of 3.5% during the forecast period of 2024-2032 to achieve a value of USD 5.4 billion by 2032. Telmisartan: Introduction Telmisartan is a widely used medication belonging to the class of angiotensin II receptor blockers (ARBs). It is primarily prescribed for the
Telmisartan Market Report 2024-2032: Key Findings and Outlook
The global Telmisartan market is on an upward trajectory, reflecting a value of USD 3.38 billion in 2023. This remarkable growth can be attributed to the increasing prevalence of cardiovascular diseases, particularly hypertension, which has been exacerbated by pandemic-induced stress, sedentary lifestyles, and a growing geriatric population. As we delve into the future, it's projected that the market will continue to expand, poised to achieve a substantial value of USD
Global Telmisartan Market Size, Segmentations, Top Key Players, Trends, & Foreca …
Telmisartan is a medication used to treat high blood pressure, heart failure, and other cardiovascular conditions. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels and improving blood flow. The global market for telmisartan is driven by a growing incidence of hypertension and other cardiovascular diseases, as well as increasing demand for effective and affordable treatments. According to a report by
Research on Global Telmisartan Market to Offer Outlook on Growth Opportunities
The most recent study on the telmisartan market by Dhirtek Business Research and Consulting provides a comprehensive view of the entire market. The research report delves deeply into the drivers and restraints of the global telmisartan market. Analysts have conducted extensive research on the global telmisartan market's milestones and current trends that will determine its future. An in-depth report on the topic was created using primary and secondary research methods.